ATRC — AtriCure, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1323885 ·
Last close
$55.02
Market Cap
$2.80B
52W High
$66.02
52W Low
$25.36
ADV30
752,681
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 154,450,000 | 119,350,000 | 4,353,000 | 4,064,000 | 717,536,000 | 187,031,000 | 184,312,000 |
| Jun 2026 | 153,604,000 | 118,629,000 | 9,665,000 | 8,955,000 | 676,643,000 | 167,786,000 | 160,210,000 |
| Mar 2026 | 141,249,000 | 109,311,000 | 526,000 | 108,000 | 643,988,000 | 146,165,000 | 152,295,000 |
| Dec 2025 | 140,500,000 | 105,337,000 | 2,491,000 | 1,756,000 | 654,179,000 | 167,428,000 | 162,244,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$68,545,000
Investing CF
$-21,108,000
Financing CF
$-7,921,000
CapEx
$-21,108,000
Dividends Paid
$0
Buybacks
$-12,527,000
EPS Diluted TTM
$0.30
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-400,076,000
Inventory
$87,310,000
Receivables
$76,128,000
ST Investments
—
EBIT TTM
$21,973,000
Pretax Income TTM
$16,197,000
Interest Exp TTM
$5,776,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$589,803,008
EBITDA
$38,197,000
Free Cash Flow
$37,145,876
Enterprise Value
$2,890,791,424
Total Cash
$187,031,008
Total Debt
$96,832,000
Shares Out
50,922,283
Trailing EPS
$0.31
Book Value
$10.47
ROE
2.9%
ROA
1.6%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 534,528,000 | -9,447,000 | — | 654,179,000 | 162,244,000 | 491,935,000 | 57,334,000 |
| Dec 2024 | 465,307,000 | -40,013,000 | -44,698,000 | 609,328,000 | 148,359,000 | 460,969,000 | 12,204,000 |
| Dec 2023 | 399,245,000 | -26,683,000 | -30,438,000 | 613,932,000 | 147,764,000 | 466,168,000 | 4,484,000 |
| Dec 2022 | 330,379,000 | -42,669,000 | -46,466,000 | 585,448,000 | 128,694,000 | 456,754,000 | -22,141,000 |
| Dec 2021 | — | — | 50,199,000 | — | — | — | — |
TTM Snapshot
Revenues TTM
$569,622,000
NetIncome TTM
$10,552,000
OpCashFlow TTM
—
Assets (Latest)
$676,643,000
Forward EPS
$0.44
Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $45.00 · spot: $55.45 · call volume: 17 · put volume: 0Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IRTC | iRhythm Holdings, Inc. | $2.98B | $89.67 | — |
| TMDX | TransMedics Group, Inc. | $3.26B | $93.91 | — |
| PLSE | PULSE BIOSCIENCES, INC. | $3.30B | $44.84 | — |
| AXGN | Axogen, Inc. | $3.31B | $55.37 | — |
| UFPT | UFP TECHNOLOGIES INC | $2.30B | $297.49 | — |
News headlines (Yahoo Finance, 1h cache)
AtriCure (ATRC) Stock Looks Fully Priced Even After Its 66% Run
2026-11-18 01:14 · Yahoo
AtriCure to Participate in the Piper Sandler 38th Annual Healthcare Conference
2026-11-17 13:00 · Yahoo
Is AtriCure (ATRC) Fully Valued After Strong Results And Raised 2026 Guidance?
2026-11-05 16:20 · Yahoo
AtriCure (ATRC) Q3 2026 Earnings Call Transcript
2026-11-04 15:29 · Yahoo
What AtriCure (ATRC) Said on Its Q3 Earnings Call
2026-11-04 00:14 · Yahoo
Compared to Estimates, AtriCure (ATRC) Q3 Earnings: A Look at Key Metrics
2026-11-03 21:30 · Yahoo
AtriCure (ATRC) Beats Q3 Earnings and Revenue Estimates
2026-11-03 21:10 · Yahoo
AtriCure: Q3 Earnings Snapshot
2026-11-03 21:07 · Yahoo
AtriCure Reports Third Quarter 2026 Financial Results
2026-11-03 21:01 · Yahoo
AtriCure to Participate at Upcoming Investor Conferences
2026-10-26 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.